acarbose vs diazoxide
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of acarbose and diazoxide. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Acarbose is a medicine that helps lower blood sugar levels in people with type 2 diabetes. It works best when used with diet and exercise.
VYKAT XR is a medicine used to treat excessive hunger in people with Prader-Willi syndrome. It helps to control their appetite.
Acarbose is used to help control blood sugar in adults with type 2 diabetes. You should use it along with a healthy diet and regular exercise. This medicine helps to keep your blood sugar from getting too high after you eat.
VYKAT XR treats hyperphagia (excessive hunger) in people aged 4 years and older who have Prader-Willi syndrome (PWS). PWS is a genetic disorder that can cause constant hunger. This medicine helps manage the strong urge to overeat.
Acarbose slows down the digestion of carbohydrates (sugars and starches) in your body. It does this by blocking certain enzymes in your small intestine that break down carbs. This helps to prevent a sharp rise in blood sugar after meals.
VYKAT XR contains diazoxide choline. It is thought to work by affecting how insulin is released in the body. This helps to reduce hunger.
- • Gas
- • Diarrhea
- • Abdominal pain
- • Increased hair growth
- • Swelling
- • High blood sugar
- • Rash
- • Fever
- Hypoglycaemia 269
- Nausea 203
- Blood Glucose Increased 200
- Dizziness 160
- Diarrhoea 147
- Hypoglycaemia 97
- Hyperglycaemia 45
- Drug Ineffective For Unapproved Indication 38
- Drug Interaction 30
- Oedema Peripheral 25
You should not take acarbose if you have diabetic ketoacidosis or cirrhosis. Also, do not take it if you have inflammatory bowel disease, colon ulcers, or any bowel obstruction. This medicine can cause liver problems in some people. Tell your doctor right away if you develop symptoms like yellowing of the skin or eyes.
VYKAT XR can cause high blood sugar, sometimes leading to a serious condition called diabetic ketoacidosis. Watch for signs like excessive thirst, frequent urination, and increased appetite with weight loss. This medicine can also cause fluid overload. Tell your doctor if you notice swelling or other signs of fluid retention.
Talk to your doctor if you are pregnant or plan to become pregnant. It is not known if acarbose will harm your unborn baby. Talk to your doctor if you are breastfeeding or plan to breastfeed. It is not known if acarbose passes into breast milk.
It is not known if VYKAT XR can harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant. It is also not known if VYKAT XR passes into breast milk. Talk to your doctor about the best way to feed your baby if you are taking this medicine.
Also Compare, Nearby Drugs
Compare acarbose with
How to Read This acarbose vs diazoxide Comparison
acarbose is classified in the Alpha-Glucosidase Inhibitor drug class, while diazoxide sits within the Potassium Channel Opener (Hyperinsulinism) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, acarbose has 979 submissions while diazoxide has 235. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for acarbose or diazoxide.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.